EAY191-N5: A Randomized Trial of Neratinib, A Pan-ErbB Inhibitor, Alone or in Combination with Palbociclib, A CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and Other Solid Tumors - A ComboMATCH Treatment Trial

Title: A Randomized Trial of Neratinib, A Pan-ErbB Inhibitor, Alone or in Combination with Palbociclib, A CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and Other Solid Tumors - A ComboMATCH Treatment Trial
Principal Investigator: Almubarak, Mohammed
Phase: II
Age Group: Adult
Applicable Disease Sites: Breast Cancer; Gastrointestinal Cancers; Genitourinary Cancers; Gynecologic Cancers; Head and Neck Cancers; Lung Cancer; Melanoma and Other Skin Cancers
Participating Institutions: Mary Babb Randolph Cancer Center
Contacts: Rachel Harper; Clinical Research Specialist; Phone: +1 304-293-6066; Email: rachel.harper@hsc.wvu.edu

Quick Search